ARCHIVES

Appropriations: Senate Committee Approves 4.5 Percent Cut To Defense Dept. Cancer Research Funding

This article is from The Cancer Letter archive.

Vol. 40 No. 30 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009

Rauscher To Become ACS VP For Research Nov. 1; Search Starts for New NCI Director

September 24, 1976

HPV Vaccine Cervarix Active In 100% Of Women In Study

July 27, 2007

Federal Standards Improve Mammogram Quality, GAO Finds

November 17, 1995